Royal Bank of Canada set a €130.00 ($151.16) price objective on Hannover Re (FRA:HNR1) in a report issued on Tuesday morning, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.
HNR1 has been the subject of several other reports. UBS Group upgraded to a neutral rating and raised their price target for the stock from GBX 945 ($12.35) to GBX 2,060 ($26.92) in a research report on Thursday, June 20th. Independent Research set a €85.00 ($98.84) price objective on Henkel AG & Co KGaA and gave the company a sell rating in a research note on Tuesday, May 7th. Societe Generale set a €119.00 ($138.37) price objective on Hannover Re and gave the company a sell rating in a research note on Wednesday, May 15th. DZ Bank reiterated a neutral rating on shares of Hannover Re in a research note on Monday, June 24th. Finally, Barclays increased their price objective on from GBX 7,500 ($98.00) to GBX 8,100 ($105.84) and gave the company an overweight rating in a research note on Monday, July 8th. Five research analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company’s stock. The company has a consensus rating of Hold and a consensus target price of €120.66 ($140.30).
HNR1 opened at €142.50 ($165.70) on Tuesday. Hannover Re has a 52 week low of €94.75 ($110.17) and a 52 week high of €116.37 ($135.31). The stock’s fifty day moving average price is €140.20.
Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The Property & Casualty Reinsurance segment offers specialty lines comprising marine, aviation, facultative, credit, surety, and political risks reinsurance products; and treaty, catastrophe XL, and structured reinsurance, as well as insurance-linked securities.
Recommended Story: Back-End Load
Receive News & Ratings for Hannover Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hannover Re and related companies with MarketBeat.com's FREE daily email newsletter.